Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 21, 2014
 
Register | Sign in
Home Page > Videos > Agrolab Labor GmbH, Bruckberg
  Videos

Return

Agrolab Labor GmbH, Bruckberg
Metrohm AG

Agrolab Group is Europe's largest privately owned laboratory services provider, with around 1000 employees at 16 locations. At Bruckberg, north of Munich, mainly agricultural, environmental, and food samples are investigated using the very latest analytical techniques. Agrolab now has two automated IC systems from Metrohm that play a key role in analyzing waste water and soils (determination of standard anions, perchlorate in soil extracts. «After almost 20 years of positive experience with Metrohm products for automated titration, we decided to change to Metrohm for ion chromatography, too», says Dr. Alexander Ruderisch, Head of the Chromatography Department, and explains why. The number one priority for him and his team is the integrated, completely automated sample preparation of his two Metrohm IC systems. These provide efficient routine analysis without expensive consumables such as syringe filters and filter caps. Not only are the samples filtered automatically, but they are also diluted to the optimum working range. Automated eluent preparation as well as Metrohm’s 10 year warranty for the anion suppressor are further benefits that prompted Agrolab in Bruckberg to choose Swiss Quality for their ion chromatography and switch to Metrohm.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Similarities and Striking Differences Found Between Mouse and Human Genome
Comparisons of both genomes’ inner workings may lead to a better use of mouse models.
New Strategy To Improve Stem Cell Transplantation
Research addresses hurdles to future transplant-based, gene-editing therapies that could help people with genetic blood diseases.
Molecular Event Mapping Opens Door to more in silico Tests
It is hoped that this new approach to mapping and predicting the impact of chemical compounds in the body could reduce the need for toxicity tests in animals.
Big Data Helps Pinpoint Possible New Stent Drug
Replacing the current drug used to coat artery-opening stents with a drug more targeted to the actual cause of stent disease could reduce blood clots and heart attacks.
Anti-Leukemia Drug May Also Work Against Ovarian Cancer
An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer – and likely other cancers as well.
Reprogramming Cells, Long Term
Positive finding could have major implications for diabetes treatment.
New Tools in Fight Against Virus that Attacks the Brain
Researchers have developed new insight into a rare but deadly brain infection, called progressive multifocal leukoencephalopathy (PML).
Novel Cancer Vaccine Approach for Brain Tumors
Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development.
Protein-engineered Cages Aid Studies of Cell Functions
The Cages, from researchers at Tokyo Institute of Technology, to deliver an important signalling molecule, carbon monoxide, into cells.
Marching to Our Own Sequences
Study finds DNA replication timing varies among people.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv